Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23258953)

1.

CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.

Shimizu Y, Dobashi K.

Mediators Inflamm. 2012;2012:475253. doi: 10.1155/2012/475253. Epub 2012 Oct 31. Review.

2.

Expression and regulation of CCL15 by human airway smooth muscle cells.

Joubert P, Lajoie-Kadoch S, Wellemans V, Létuvé S, Tulic MK, Halayko AJ, Hamid Q.

Clin Exp Allergy. 2012 Jan;42(1):85-94. doi: 10.1111/j.1365-2222.2011.03894.x. Epub 2011 Nov 9.

PMID:
22092970
3.

MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.

Ramos CD, Canetti C, Souto JT, Silva JS, Hogaboam CM, Ferreira SH, Cunha FQ.

J Leukoc Biol. 2005 Jul;78(1):167-77. Epub 2005 Apr 14.

4.

Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.

Escher SE, Forssmann U, Frimpong-Boateng A, Adermann K, Vakili J, Sticht H, Detheux M.

J Pept Res. 2004 Jan;63(1):36-47.

PMID:
14984572
5.

Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation.

Fahy JV.

J Allergy Clin Immunol. 2006 Jun;117(6):1230-2. Review.

PMID:
16750979
6.

Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.

Hwang J, Kim CW, Son KN, Han KY, Lee KH, Kleinman HK, Ko J, Na DS, Kwon BS, Gho YS, Kim J.

FEBS Lett. 2004 Jul 16;570(1-3):47-51.

7.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
9.

Expression and regulation of CCR1 by airway smooth muscle cells in asthma.

Joubert P, Lajoie-Kadoch S, Welman M, Dragon S, Létuvée S, Tolloczko B, Halayko AJ, Gounni AS, Maghni K, Hamid Q.

J Immunol. 2008 Jan 15;180(2):1268-75.

10.

[Anti-immunoglobulin E, a monoclonal antibody to treat respiratory disorders].

Cabrera-Navarro P.

Arch Bronconeumol. 2006 May;42(5):241-5. Review. Spanish.

11.

CCR1-mediated STAT3 tyrosine phosphorylation and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Gα(14/16) signaling and IL-6 release.

Lee MM, Chui RK, Tam IY, Lau AH, Wong YH.

J Immunol. 2012 Dec 1;189(11):5266-76. doi: 10.4049/jimmunol.1103359. Epub 2012 Nov 2.

12.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
13.

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. Epub 2004 Jun 1.

PMID:
15172898
14.
15.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
16.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
17.

The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.

Moss RB.

Ann N Y Acad Sci. 2012 Dec;1272:49-57. doi: 10.1111/j.1749-6632.2012.06810.x.

PMID:
23231714
18.

Targeting IgE in asthma.

Kuhl K, Hanania NA.

Curr Opin Pulm Med. 2012 Jan;18(1):1-5. doi: 10.1097/MCP.0b013e32834deebb. Review.

PMID:
22139745
19.

Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.

Shimizu Y, Dobashi K, Fueki N, Fueki M, Okada T, Tomioka S, Makino S, Mori M.

J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):177-86.

PMID:
21880206
20.

Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):227-9. Review.

PMID:
15379589
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk